In this prospective longitudinal study, we showed that levels of the CSF biomarkers tau, P‐tau, α‐syn, NFL, and YKL‐40 increase significantly over a period of 2 years selectively in the PD group, whereas control individuals had stable levels. This evidence concerns the gene CHI3L1 and Parkinson disease.